Uncertainty surrounding how truncated titin proteins (TTNtvs) cause dilated cardiomyopathy (DCM) and peripartum cardiomyopathy (PPCM) led to investigations that could better inform therapies for these ...

When heart muscle gets damaged, the result is often permanent. Unlike other muscles in the body, the heart has long been believed to lack the ability to heal itself. But recent research suggests that ...

Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to ...

A new small study led by Johns Hopkins Medicine researchers and published July 25 th in the journal Nature Cardiovascular Research has revealed the impact of obesity on muscle structure in patients ...

Type 2 diabetes doesn’t just raise the risk of heart disease—it physically reshapes the heart itself. Researchers studying donated human hearts found that diabetes disrupts how heart cells produce ...

Phase II ARCHER trial showed a significant reduction in left ventricular (LV) mass (p=0.0117) and improvements in multiple key cardiac MRI (CMR) measures of structural heart recovery in patients with ...